The Honest Company, Inc. (NASDAQ:HNST) Receives $3.00 Consensus Target Price from Analysts
The Honest Company, Inc. (NASDAQ:HNST – Get Free Report) has earned an average rating of “Reduce” from the seven ratings firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the […]
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives $15.00 Consensus Target Price from Analysts
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX – Get Free Report) has been given an average rating of “Moderate Buy” by the eight brokerages that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a buy recommendation and two have given a strong buy recommendation to […]
Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives $19.50 Consensus Price Target from Analysts
Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have received a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and ten have given a buy recommendation […]
Coca-Cola Europacific Partners (NASDAQ:CCEP) Receives $107.71 Consensus Target Price from Analysts
Coca-Cola Europacific Partners (NASDAQ:CCEP – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten ratings firms that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 […]
Microbot Medical Inc. (NASDAQ:MBOT) Receives $7.50 Consensus Price Target from Analysts
Shares of Microbot Medical Inc. (NASDAQ:MBOT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five research firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, two have given a buy recommendation and […]
Arq, Inc. (NASDAQ:ARQ) Receives $7.50 Consensus Target Price from Analysts
Shares of Arq, Inc. (NASDAQ:ARQ – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, two have issued a buy recommendation and […]
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives $76.63 Consensus Target Price from Analysts
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation to […]
Sabre Corporation (NASDAQ:SABR) Receives $2.35 Consensus Target Price from Analysts
Sabre Corporation (NASDAQ:SABR – Get Free Report) has been given an average recommendation of “Reduce” by the six analysts that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company. The average twelve-month target price among analysts that […]
easyJet plc (LON:EZJ) Receives GBX 607.14 Consensus Target Price from Analysts
Shares of easyJet plc (LON:EZJ – Get Free Report) have earned a consensus recommendation of “Hold” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on […]
OptimizeRx Corp. (NASDAQ:OPRX) Receives $17.57 Consensus Target Price from Analysts
OptimizeRx Corp. (NASDAQ:OPRX – Get Free Report) has earned an average rating of “Moderate Buy” from the nine research firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, six have issued a buy rating and one has given a […]
The Real Brokerage Inc. (NASDAQ:REAX) Receives $5.75 Consensus Price Target from Analysts
Shares of The Real Brokerage Inc. (NASDAQ:REAX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, four have given a buy recommendation […]
Benitec Biopharma Limited (NASDAQ:BNTC) Receives $27.67 Consensus Price Target from Analysts
Shares of Benitec Biopharma Limited (NASDAQ:BNTC – Get Free Report) have received an average rating of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating […]
Natera, Inc. (NASDAQ:NTRA) Receives $253.47 Consensus Target Price from Analysts
Shares of Natera, Inc. (NASDAQ:NTRA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eighteen ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, thirteen have given a buy recommendation […]
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $42.67 Consensus Price Target from Analysts
Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have earned an average recommendation of “Hold” from the twelve ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, four have assigned a buy recommendation and […]
Diamondback Energy, Inc. (NASDAQ:FANG) Receives $195.43 Consensus Target Price from Analysts
Shares of Diamondback Energy, Inc. (NASDAQ:FANG – Get Free Report) have been assigned a consensus rating of “Buy” from the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation, twenty have issued a buy recommendation and three have assigned a strong buy recommendation […]
last updated on 5 Apr 15:42